2002 Archive

• PROTEOME SCIENCES COLLABORATION AND LICENSING DEAL FOR STROKE
  20th December 2002

• INTRONN WINS FURTHER RECOGNITION
  25th November 2002

• INTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2002
  HIGHLIGHTS
  30th September 2002

• PROTEOME SCIENCES ANNOUNCES TWO BOARD APPOINTMENTS: DR. WOLFGANG SCHÜLLER AS A NON-EXECUTIVE DIRECTOR AND JAMES GREEN AS COMMERCIAL DIRECTOR
  23rd July 2002

• COMPLETION OF PURCHASE FROM AVENTIS R & T
  4th July 2002

• REPORT AND ACCOUNTS 31 DECEMBER NOW AVAILABLE
  24th June 2002

• PRELIMINARY STATEMENT FOR THE YEAR ENDED 31ST DECEMBER, 2001
  5% PLACING TO RAISE £2.6 M
  31st May 2002

• ACQUISITION OF AVENTIS R AND T PROTEOMICS DIVISION
  31st May 2002

• PROTEOME SCIENCES ANNOUNCES HIGH SPECIFICITY BLOOD TEST FOR STROKE
  1st May 2002

• PROTEOME SCIENCES APPOINTS JAMES GREEN AS BUSINESS DEVELOPMENT DIRECTOR
  26th April 2002

• PROTEOME SCIENCES APPLIES PROTEOMICS EXPERTISE IN THE AREA OF STROKE IN A COLLABORATION WITH RENEURON TO IDENTIFY BRAIN REPAIR PROTEINS
  27th February 2002

• PROTEOME SCIENCES IS GRANTED PATENT TO DETECT nvCJD AND BSE IN BLOOD
  30th January 2002

• INTRONN'S SMaRT GENE THERAPY CORRECTS CYSTIC FIBROSIS GENE DEFECT IN HUMAN LUNG CELL MODEL
  14th January 2002